Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy MetLife (MET) stocks in Canada

Learn how to easily invest in MetLife stocks.

MetLife is an insurance-life business based in the US. MetLife stocks (MET.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $60.88 – a decrease of 1.62% over the previous week. MetLife employs 0 staff and has a trailing 12-month revenue of around $71.1 billion.

How to buy stocks in MetLife

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

MetLife stock price (NYSE:MET)

Use our graph to track the performance of MET stocks over time.

MetLife shares at a glance

Information last updated 2022-05-16.
Latest market close$62.39
52-week range$53.58 - $72.64
50-day moving average $68.03
200-day moving average $64.73
Wall St. target price$78.15
PE ratio 8.6758
Dividend yield $1.9 (3.15%)
Earnings per share (TTM) $7.31

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy MetLife stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

MetLife price performance over time

Historical closes compared with the close of $62.39 from 2022-05-19

1 week (2022-05-13) -1.62%
1 month (2022-04-20) -13.87%
3 months (2022-02-18) -10.29%
6 months (2021-11-19) 2.03%
1 year (2021-05-20) -3.21%
2 years (2020-05-20) 88.15%
3 years (2019-05-20) 31.29%
5 years (2017-05-19) 23.61%

Is MetLife under- or over-valued?

Valuing MetLife stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MetLife's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

MetLife's P/E ratio

MetLife's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, MetLife shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

MetLife's PEG ratio

MetLife's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.4413. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MetLife's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

MetLife's EBITDA

MetLife's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.5 billion.

The EBITDA is a measure of a MetLife's overall financial performance and is widely used to measure a its profitability.

MetLife financials

Revenue TTM $71.1 billion
Operating margin TTM 12.72%
Gross profit TTM $20.7 billion
Return on assets TTM 0.73%
Return on equity TTM 9.22%
Profit margin 9.22%
Book value $81.74
Market capitalisation $51.6 billion

TTM: trailing 12 months

MetLife's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MetLife.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

MetLife's total ESG risk score

Total ESG risk: 18.05

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MetLife's overall score of 18.05 (as at 01/01/2019) is excellent – landing it in it in the 17th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like MetLife is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

MetLife's environmental score

Environmental score: 0.62/100

MetLife's environmental score of 0.62 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that MetLife is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

MetLife's social score

Social score: 7.35/100

MetLife's social score of 7.35 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that MetLife is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

MetLife's governance score

Governance score: 9.83/100

MetLife's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that MetLife is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

MetLife's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. MetLife scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that MetLife has, for the most part, managed to keep its nose clean.

MetLife share dividends


Dividend payout ratio: 21.7% of net profits

Recently MetLife has paid out, on average, around 21.7% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MetLife shareholders could enjoy a 3.15% return on their shares, in the form of dividend payments. In MetLife's case, that would currently equate to about $1.9 per share.

While MetLife's payout ratio might seem low, this can signify that MetLife is investing more in its future growth.

MetLife's most recent dividend payout was on 14 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 9 May 2022 (the "ex-dividend date").

Have MetLife's shares ever split?

MetLife's shares were split on a 1122:1000 basis on 7 August 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1122 shares. This wouldn't directly have changed the overall worth of your MetLife shares – just the quantity. However, indirectly, the new 10.9% lower share price could have impacted the market appetite for MetLife shares which in turn could have impacted MetLife's share price.

MetLife share price volatility

Over the last 12 months, MetLife's shares have ranged in value from as little as $53.5847 up to $72.6383. A popular way to gauge a stock's volatility is its "beta".

MET.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MetLife's is 1.1843. This would suggest that MetLife's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

MetLife overview

MetLife, Inc. , a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U. S. ; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site